Q301--Genomic Sequencing Classifier

Closed Pre-Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36C25625Q0001
Agency
Veterans Integrated Service Network 16 Veterans Health Administration, Department of Veterans Affairs
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
621511 Medical Laboratories
PSC
Q301 Reference Laboratory Testing
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

Paragraph 1:

The Department of Veterans Affairs (VA) Network Contracting Office 16 is conducting market research to identify potential vendors capable of providing the Afirma Genomic Sequencing Classifier, a genetic test used to determine if a thyroid has a malignancy for veterans who are poor candidates for surgery due to multiple comorbidities. The purpose is to gain knowledge of potential qualified sources and their size classification relative to NAICS 621511 (Medical Laboratories) and PSC Q301 (Medical-Laboratory Testing). Interested vendors are requested to submit information on their company, socioeconomic status, capabilities, and estimated pricing by August 8, 2024 at 12:00 PM Central Time.

Paragraph 2:

This is a sources sought announcement only, and no set-aside designation is mentioned. If there are no responses, the VA may sole source the requirement to Veracyte Inc. No specific award value or budget range is provided, and the notice states that this is not a solicitation and no contract will be awarded as a result of this announcement.

Notice text

This is a sources sought announcement only. This is not a solicitation for proposals and no contract will be award from this announcement.

The purpose of this announcement is to perform market research to gain knowledge of potential qualified sources and their size classification relative to NAICS 621511, Medical Laboratories, Product Service Code Q301, Medical- Laboratory Testing with a size standard of $41.5 Million.

The VHA Network Contracting Office (NCO) 16 is seeking to identify any vendor capable of providing the Afirma® Genomic Sequencing Classifier. This test is a genetic classifier that measures the expression of 167 genes to determine if the thyroid has a malignancy for Veterans that are poor candidates for surgery due to multiple comorbidities in support of the G.V. (Sonny) Montgomery, VA Medical Center (VAMC), Pathology & Laboratory Medicine Service (P&LMS), Jackson, MS, and the Veterans Healthcare System of the Ozarks, P&LMS, located at 1100 N. College Ave, Fayetteville, AR and potentially other VISN 16 medical facilities. Veteran healthcare and patient safety are paramount and non-negotiable within the mission of the Department of Veteran Affairs.

Responses to this sources sought must include the following information:

1. Your company name, address, contact person name, phone number, fax number, e-mail address(s) and ueiSAM number (i.e. LV91LJ4B1Z98), DUNS number, and company website if available.

2. Your company GSA/FSS contract number if available.

3. Socio-economic status of the business (i.e. SDVOSB/VOSB, 8(a), HUB Zone, Women Owned Small Business, Small disadvantaged business, or Small Business HUB Zone business)

4. Capability statements addressing the particulars of this effort, with appropriate documentation supporting claims of organizational and staff capabilities are sought. If significant subcontracting or teaming is anticipated in order to deliver technical capability, organizations should address the administrative and management structure of such arrangements.

5. Vendors are requested to submit estimated market research pricing with their responses. The estimated pricing will be considered when determining a procurement strategy for the future requirements.

6. Notice of Intent to Sole Source. If there are no responses to this notice, a determination by the Government not to compete based upon responses to this notice is solely within the discretion of the Government to sole source to Veracyte Inc. No response is a response.

Interested vendor should submit an email to troy.davis@va.gov. All responses must be received in writing no later than 12:00 PM CST/local time on August 8, 2024 and shall include all necessary documentation on the ability to satisfy the Government s requirements. Vague or incomplete submissions of capabilities will be considered dated, inaccurate, and irrelevant market research information and will not be used in the development of any acquisition plan or procurement strategy. Questions or inquiries will not be answered or acknowledged, and no feedback will be provided. This is not a solicitation and there is no solicitation document available at this time.

DISCLAIMER: This notice is issued solely for informational and planning purposes and does not constitute a solicitation. Responses to this notice are not offers and cannot be accepted by the Department of Veterans Affairs to form a binding contract. Respondents are solely responsible for all expenses associated with responding to this notice.

Attachments

Files attached to this notice, newest first
File Type Posted
36C25625Q0001.docx DOCX document

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Q301--Veracyte-Afirma Testing 564-25-1-140-0032 (VA-24-00071277) Award Award Notice
Q301--Genomic Sequencing Classifier This notice · Latest pre-solicitation Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity